Tiny Health Celebrates 100,000 Tests Milestone, Expands from Baby Gut Health Pioneer to Longevity Innovator (Globe Newswire)

Tiny Health, the microbiome testing company best known for its infant gut health platform, says it has surpassed 100,000 tests and is now pushing aggressively into the longevity market. Backed by a randomized controlled trial in infants showing an 83% reduction in eczema risk, the company is extending its science to adults with new microbiome-based markers tied to metabolic health, GLP-1 production, inflammation, and aging resilience. Alongside the milestone, Tiny Health launched a new Microbiome Age study for adults over 60 and expanded partnerships with longevity clinics and preventive health programs, positioning the gut microbiome as a core signal for long-term healthspan—not just early-life disease prevention.